The Expert Report to the Inquiry Blood Inquiry: Hepatitis referred to variability throughout the UK in referral to specialist palliative care and access to palliative care services for patients with chronic liver disease. Read more about The Expert Report to the Inquiry Blood Inquiry: Hepatitis referred to variability throughout the UK in referral to specialist palliative care and access to palliative care services for patients with chronic liver disease.
Pegylated interferon was used as monotherapy in the UK from June 2002 and was deemed to provide better results. Read more about Pegylated interferon was used as monotherapy in the UK from June 2002 and was deemed to provide better results.
Direct-acting antivirals became available for treatment for Hepatitis C. Read more about Direct-acting antivirals became available for treatment for Hepatitis C.
Interferon was used in some specialist centres (on a named person basis) for some five years prior to licensing. Read more about Interferon was used in some specialist centres (on a named person basis) for some five years prior to licensing.
Interferon alpha monotherapy was the only treatment licensed for use in treatment of Hepatitis C in the UK. Read more about Interferon alpha monotherapy was the only treatment licensed for use in treatment of Hepatitis C in the UK.
Combination therapy was the mainstay of treatment from 2000, with interferon being part of the combination until around 2014. Read more about Combination therapy was the mainstay of treatment from 2000, with interferon being part of the combination until around 2014.
The effectiveness of interferon against Hepatitis C was demonstrated for the first time by Dr Jay Hoofnagle. Read more about The effectiveness of interferon against Hepatitis C was demonstrated for the first time by Dr Jay Hoofnagle.
Letter from Dr Dr K Bywater to Dr Kenneth Calman stated that although Interferon treatment was licensed for use in January 1995 it had been used in specialist centres in the UK and around the world for the previous 5 years. Read more about Letter from Dr Dr K Bywater to Dr Kenneth Calman stated that although Interferon treatment was licensed for use in January 1995 it had been used in specialist centres in the UK and around the world for the previous 5 years.
A paper containing an economic analaysis of screening blood donations against Hepatitis C referred to a research programme a research programme had begun to evaluate the use of interferon therapy in non-A non-B Hepatitis. Read more about A paper containing an economic analaysis of screening blood donations against Hepatitis C referred to a research programme a research programme had begun to evaluate the use of interferon therapy in non-A non-B Hepatitis.
Michelle Tolley described the differences in care at two hospitals:"you have your scan, you might wait three or four weeks for a letter and then you see your hepatologist, if you're lucky, and then you get sent off for bloods ... not like at King's [College Hospital], where you have your scan in the morning, your bloods, and then you see the person in the afternoon. That's all done and dusted." Read more about Michelle Tolley described the differences in care at two hospitals:"you have your scan, you might wait three or four weeks for a letter and then you see your hepatologist, if you're lucky, and then you get sent off for bloods ... not like at King's [College Hospital], where you have your scan in the morning, your bloods, and then you see the person in the afternoon. That's all done and dusted."